Jiangsu Lanfeng Bio-chemical Co Ltd
SZSE:002513
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Jiangsu Lanfeng Bio-chemical Co Ltd
SZSE:002513
|
CN |
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
US |
|
C
|
China Shineway Pharmaceutical Group Ltd
HKEX:2877
|
CN |
|
Jiangsu Xiehe Electronic Co Ltd
SSE:605258
|
CN |
|
A
|
Amneal Pharmaceuticals Inc
F:2DT
|
US |
|
Panoramic Resources Ltd
ASX:PAN
|
AU |
|
A
|
Aveanna Healthcare Holdings Inc
NASDAQ:AVAH
|
US |
|
D
|
Doosan Robotics Inc
KRX:454910
|
KR |
|
A
|
Aegean Airlines SA
ATHEX:AEGN
|
GR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Jiangsu Lanfeng Bio-chemical Co Ltd's stock price target?
Not Available
Jiangsu Lanfeng Bio-chemical Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Jiangsu Lanfeng Bio-chemical Co Ltd's Revenue forecast?
Projected CAGR
-1%
For the last 13 years the compound annual growth rate for Jiangsu Lanfeng Bio-chemical Co Ltd's revenue is 4%. The projected CAGR for the next 7 years is -1%.